​Inotiv discloses FCPA probe into primate importation practices

Primates

Inotiv disclosed the Securities and Exchange Commission (SEC) is investigating potential violations of the Foreign Corrupt Practices Act (FCPA) by the pharmaceutical testing company regarding its importation of nonhuman primates (NHPs) from Asia.

In May, the SEC requested documents and information from Inotiv and two of its subsidiaries—Envigo Global Services and Orient BioResource Center—for the period beginning Dec. 1, 2017, to present, Inotiv revealed in a regulatory filing Friday.

The company said it is cooperating with the probe.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.